News for Bayer Aktiengesellschaft (BAYER.BD)

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock’s risk/reward profile appears positive as it approaches H2 2025, with potential catalysts that could drive a re-rating in the medium term. This upgrade follows Bayer’s strong operational […]

Bayer's 2024 annual results showed a 2.2% sales decline, with only free cash flow improving significantly. Read why BAYZF stock is a Buy.

Bayer Aktiengesellschaft (OTCPK:BAYZF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ETCompany ParticipantsJost Reinhard - IRBill Anderson -...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.

BOC leverages opening-up of Chinese capital markets to grow into a more internationalized and multifunctional bank

The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2024 Q3 earnings call.

Zenas BioPharma has filed to raise $100 million in an IPO to advance its Phase 3 and Phase 2 trials for obexelimab. Click here to read an analysis of ZBIO stock.

ClearPoint Neuro provides tools for minimally invasive brain surgeries, neurosurgical laser therapy, and drug delivery to the brain. Learn more on CLPT stock here.

Bayer reported 2Q results and the results were nothing to get excited about. Check out why I will keep my neutral rating at this point for BAYRY stock.

Aug 06, 2024 / 12:00PM GMTEditor Please stand by for streaming text.Bill Anderson - Bayer Aktiengesellschaft - Chairman Consumers with trust and self-care. That

Bayer Aktiengesellschaft (OTCPK:BAYZF) Q2 2024 Earnings Conference Call August 6, 2024 8:00 AM ETCompany ParticipantsJost Reinhard - IRWilliam N.

The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2024 Q2 earnings call.

The Global Patient-Centric Healthcare App Market Size was Valued at USD 11.90 Billion in 2023 and the Worldwide Global Patient-Centric Healthcare App...

In this piece, we will take a look at the 15 biggest agriculture stocks in 2024.

In this article, we will look into the 15 countries that produce the most genetically modified crops.

Third Quarter 2023 Financial Results Revenue of $1,068 million, representing 4% reported growth or 5% excluding the impact of foreign exchange rates Reported Net Loss of $1,096 million,...

Elanco Animal Health Reports Third Quarter 2023 Results •Third Quarter 2023 Financial Results ◦Revenue of $1,068 million, representing 4% reported growth or...

/PRNewswire/ -- The "Patient Centric Healthcare App Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been...

The ongoing Russian invasion of Ukraine, which is about to enter a full twelve months upended global agriculture supply chains.